Core Scientific (CORZR) Invested Capital (2020 - 2026)

Core Scientific has disclosed Invested Capital across 7 years of filings, most recently posting -$220.7 million for Q1 2026.

• Invested Capital for Q1 2026 came in at -$220.7 million, up 28.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$220.7 million (up 28.27% YoY), and the FY2025 annual result was -$962.7 million, down 2.27% from the prior year.
• Invested Capital came in at -$220.7 million for Q1 2026 at Core Scientific, up from -$962.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.2 billion in Q1 2022 to a low of -$1.3 billion in Q3 2025.
• The 5-year median for Invested Capital is -$397.5 million (2023), against an average of -$445.5 million.
• Across the five-year window, Invested Capital surged 912.69% in 2022 and sank 348.5% in 2023, its largest moves.
• Core Scientific's Invested Capital stood at -$409.3 million in 2022, then sank by 32.27% to -$541.4 million in 2023, then tumbled by 73.87% to -$941.4 million in 2024, then slipped by 2.27% to -$962.7 million in 2025, then soared by 77.08% to -$220.7 million in 2026.
• The last three Invested Capital figures came in at -$220.7 million (Q1 2026), -$962.7 million (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.